Technology
Health
Pharmaceutical
Verona Pharma
$4.179876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$4.17
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.01 (0.24%) Today
$0.00 (0.00%) As of 3:59 PM EDT after-hours
Why Robinhood?
You can buy or sell Verona Pharma and other stocks, options, ETFs, and crypto commission-free!
About VRNA
Verona Pharma Plc operates as a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases. It's product include, RPL554, is a dual inhibitor of the enzymes phosphodiesterase 3 and 4 that acts as both a bronchodilator and an anti-inflammatory agent in a single compound. Read More The firm develops RPL554 for the treatment of chronic obstructive pulmonary disease (COPD), cystic fibrosis, and potentially asthma. The company was founded by Michael J. A. Walker and Clive P. Page on February 24, 2005 and is headquartered in London, United Kingdom.
Employees
—
Headquarters
London, Greater London
Founded
2005
Market Cap
54.77M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
5.76K
High Today
$4.25
Low Today
$4.15
Open Price
$4.16
Volume
1.03K
52 Week High
$14.50
52 Week Low
$3.65
Collections
Technology
Health
Pharmaceutical
Medical
Biopharmaceutical
Therapy
2017 IPO
UK
Price Paid on Robinhood
59% Lower
Right Now
52 Week Low
$5.52
Average Price Paid
$10.11
52 Week High
$18.20
Analyst Ratings
83%
of 6 ratings
Buy
83%
Hold
17%
Sell
0%
VRNA Earnings
-$0.73
-$0.48
-$0.24
$0.01
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.59 per share
Actual
-$0.10 per share